Pharmaceutical Due Diligence Services
Supporting acquisitions, licensing deals, investments and strategic partnerships across pharmaceuticals, biotech, and medical device companies.
Due Diligence Expertise
Boyds' expertise across the core disciplines underlying drug development allows us to carry out technical, regulatory and commercial due diligence, enabling our clients to make the correct decisions.
- 20+ years supporting critical development and investment decisions across the pharmaceutical and biotechnology sectors
- Scientific, clinical, regulatory and CMC expertise under one roof
- Experience across pharmaceutical, biotech and medical device products, including small molecules, biologics, advanced therapies and combination products.
- Independent assessment of development risk and value
Contact Our Due Diligence Experts
Due Diligence Support for Pharmaceutical, Biotech and Medical Device Products
Whether you are looking to acquire or in-license products, development programs, or biotech companies; or to out-license products or drug development programs, high-quality decision-making needs to be led by a detailed and accurate assessment of the available scientific data.
Our highly experienced team at Boyds supports the development of medicines across a wide range of product types and therapeutic areas. We use our knowledge and expertise to carry out a detailed analysis of the product development and regulatory requirements to ensure a detailed due diligence process.
Boyds is experienced in reviewing pre-clinical, CMC, regulatory and clinical data, presenting reports to clients, and assessing the risks and benefits of the programs under consideration. We scrutinize the relevant data for the product and report the findings to highlight areas of concern and additional work that will be required to obtain licensure and commercialization.
Our balanced scientific approach, in-depth knowledge of the EU regulatory environment and years of experience at all stages of product development will help ensure there are no surprises when the deal is done.
Decision-making needs accurate information. We delve deep into the available data to create a bespoke report based on the requirements of the asset in question and use the following principles to identify any red flags:
What We Assess During Due Diligence
Clinical Development
Regulatory Strategy
CMC and Manufacturing
Intellectual Property
Safety and Toxicology
Competitive Landscape
Success stories
Considering an acquisition, licensing deal, investment or strategic partnership?
Our scientific, regulatory, clinical and CMC experts provide independent due diligence to help you identify risks, validate assumptions and make informed decisions.
Get in touch
If you would like to talk to a member of our team about a specific project or area of expertise, then please complete this form and we will get in touch.